Accelerate Diagnostics Inc. (AXDX): A Brand-New Prospect for Investors – Invest Chronicle
Home  »  Finance   »  Accelerate Diagnostics Inc. (AXDX): A Brand-New Pr...

Accelerate Diagnostics Inc. (AXDX): A Brand-New Prospect for Investors

Accelerate Diagnostics Inc. (AXDX) is priced at $1.12 after the most recent trading session. At the very opening of the session, the stock price was $0.88 and reached a high price of $1.12, prior to closing the session it reached the value of $0.87. The stock touched a low price of $0.88.Recently in News on May 23, 2022, Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022. Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief Executive Officer, Jack Phillips, will present at the 42nd Annual William Blair Growth Stock Conference on Thursday, June 7, 2022, at 10:00 AM Central Time. You can read further details here

Accelerate Diagnostics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.3100 on 01/03/22, with the lowest value was $0.5020 for the same time period, recorded on 05/20/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Accelerate Diagnostics Inc. (AXDX) full year performance was -86.14%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Accelerate Diagnostics Inc. shares are logging -87.93% during the 52-week period from high price, and 123.11% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.50 and $9.28.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1958594 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Accelerate Diagnostics Inc. (AXDX) recorded performance in the market was -78.54%, having the revenues showcasing -35.63% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 92.04M, as it employees total of 220 workers.

The Analysts eye on Accelerate Diagnostics Inc. (AXDX)

During the last month, 1 analysts gave the Accelerate Diagnostics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 1.5094, with a change in the price was noted -1.74. In a similar fashion, Accelerate Diagnostics Inc. posted a movement of -60.84% for the period of last 100 days, recording 767,160 in trading volumes.

Technical rundown of Accelerate Diagnostics Inc. (AXDX)

Raw Stochastic average of Accelerate Diagnostics Inc. in the period of last 50 days is set at 80.47%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 79.73%. In the last 20 days, the company’s Stochastic %K was 58.04% and its Stochastic %D was recorded 51.57%.

Considering, the past performance of Accelerate Diagnostics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -78.54%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -76.72%, alongside a downfall of -86.14% for the period of the last 12 months. The shares increased approximately by 59.86% in the 7-day charts and went down by 106.00% in the period of the last 30 days. Common stock shares were lifted by -35.63% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts